rs786202363
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000179.3(MSH6):c.1316A>G(p.Asp439Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000179.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary nonpolyposis colorectal neoplasms Pathogenic:1
This sequence change replaces aspartic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 439 of the MSH6 protein (p.Asp439Gly). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with Lynch syndrome and/or constitutional mismatch repair deficiency syndrome (PMID: 30013564; internal data). Invitae Evidence Modeling of clinical and family history, age, sex, and reported ancestry of multiple individuals with this MSH6 variant has been performed. This variant is expected to be pathogenic with a positive predictive value of at least 99%. This is a validated machine learning model that incorporates the clinical features of 1,370,736 individuals referred to our laboratory for MSH6 testing. ClinVar contains an entry for this variant (Variation ID: 185673). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on MSH6 protein function. For these reasons, this variant has been classified as Pathogenic. -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.D439G variant (also known as c.1316A>G), located in coding exon 4 of the MSH6 gene, results from an A to G substitution at nucleotide position 1316. The aspartic acid at codon 439 is replaced by glycine, an amino acid with similar properties. This alteration is identified in an individual whose colorectal tumor was microsatellite stable and demonstrated normal mismatch repair protein expression on immunohistochemistry (IHC); however, this alteration is also identified in individuals whose Lynch-related tumors demonstrated high microsatellite instability and/or loss of MSH6 expression on IHC, and in an individual whose colorectal tumor was microsatellite stable but demonstrated loss of MSH6 expression on IHC (Ambry internal data). This alteration is identified in conjunction with a pathogenic alteration in MSH6 (phase unknown) in a four year-old male with clinical features consistent with CMMRD (Tesch VK et al. Front Immunol, 2018 Jul;9:1506). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at